[HTML][HTML] High-dose intravenous immunoglobulin in skin autoimmune disease
JHO Hoffmann, AH Enk - Frontiers in immunology, 2019 - frontiersin.org
… use of IVIg, a comprehensive clinical guideline for the use of IVIg in … The pathogenic relevance
of FcRn in autoimmune bullous … The skin is usually affected in a UV-dependent fashion. …
of FcRn in autoimmune bullous … The skin is usually affected in a UV-dependent fashion. …
High‐dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases
JHO Hoffmann, AH Enk - JDDG: Journal der Deutschen …, 2017 - Wiley Online Library
… In autoimmune bullous diseases, IVIGs can be used in an … explained by an exclusively
FcRn-dependent mechanism. Finally, it … The full text of this article hosted at iucr.org is unavailable …
FcRn-dependent mechanism. Finally, it … The full text of this article hosted at iucr.org is unavailable …
[HTML][HTML] Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fcγ …
A Shock, D Humphreys, F Nimmerjahn - Journal of Allergy and Clinical …, 2020 - Elsevier
… , and various skin blistering diseases severely impacts quality of … both FcRn and the family
of canonical FcγRs are central to IgG (… on how IVIg may modulate IgG-dependent autoimmune …
of canonical FcγRs are central to IgG (… on how IVIg may modulate IgG-dependent autoimmune …
Biological therapy of autoimmune blistering diseases
M Alaibac - Expert Opinion on Biological Therapy, 2019 - Taylor & Francis
… FcRn mAb which determined sustained dose-dependent … procedure applied to remove
total IgG from patient plasma using … Intravenous immunoglobulin (IVIG) treatment is utilized to …
total IgG from patient plasma using … Intravenous immunoglobulin (IVIG) treatment is utilized to …
Clinical significance of serum albumin and implications of FcRn inhibitor treatment in IgG-mediated autoimmune disorders
… As such, in addition to liver synthesis, pH-dependent FcRn … Treatment with intravenous
immunoglobulin (IVIg) may further … in FcRn inhibitor design, such as format (full-length IgG vs Fc …
immunoglobulin (IVIg) may further … in FcRn inhibitor design, such as format (full-length IgG vs Fc …
Role of intravenous immunoglobulin in dermatologic disorders
… Our current understanding of IVIg is dependent on the underlying disease process, and the
… FcRn appears to have an important role in autoimmune bullous disease as FcRn deficient …
… FcRn appears to have an important role in autoimmune bullous disease as FcRn deficient …
From bench to bedside: Evolving therapeutic targets in autoimmune blistering disease
K Kridin, EH Kowalski, D Kneiber… - Journal of the …, 2019 - Wiley Online Library
… achieved complete remission on therapy within 2 months and … diminish blister formation in
a dose-dependent fashion.103, 105 … In the circulation, FcRn protects circulating IgG antibodies …
a dose-dependent fashion.103, 105 … In the circulation, FcRn protects circulating IgG antibodies …
[HTML][HTML] … intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg …
MC Dalakas - Neurotherapeutics, 2021 - Elsevier
… trials are completed, the information that IVIg preparations contain … of IgG derived from IVIg
administrations saturate the FcRn so … IVIg causes a dose-dependent downregulation on their …
administrations saturate the FcRn so … IVIg causes a dose-dependent downregulation on their …
IVIG in autoimmune disease—Potential next generation biologics
AW Zuercher, R Spirig, AB Morelli, F Käsermann - Autoimmunity reviews, 2016 - Elsevier
… are mostly dependent on the constant Fc portion of the IgG … tracer IgG is significantly enhanced
by blockade of FcRn with … ), MG and skin blistering diseases have been communicated on …
by blockade of FcRn with … ), MG and skin blistering diseases have been communicated on …
Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis
JT Guptill, JW Sleasman, S Steeland, M Sips… - …, 2022 - Taylor & Francis
… in multiple autoimmune diseases, reducing total IgG could … randomised 1:1 to efgartigimod
IV 10 mg/kg or placebo. A … In our study, an IgG response to T-cell dependent vaccines was …
IV 10 mg/kg or placebo. A … In our study, an IgG response to T-cell dependent vaccines was …